Blood Glucose Control

Diabetes has long been divided into type 1 and type 2. But a third type has entered the mix — and we aren't diagnosing it correctly.

Sensor-augmented therapy can diminish hypoglycemia with the low-glucose suspend feature.

OptiScanner is the first-of-its-kind bedside blood monitoring platform that provides plasma-based, automated monitoring of ICU patients’ glucose levels. The OptiScanner 5000 directly measures plasma glucose levels using an integrated blood centrifuge and spectrometer to help avoid dangerous glycemic variations and assist clinicians in achieving the right level of glucose control.

A new formulation of Insulin Aspart can offer better glycemic control and may also be given after meals.

Trial shows HbA1c reduced, hypoglycemia and DKA similar across study participants.

Increased cardio risk of Saxagliptin found during trial prompts FDA decision.

Trial results promising, but DKA still a concern with use of new once-daily pills.

Common osteoarthritis treatment may be beneficial in lowering HbA1c.

Intensive control of blood pressure, glucose, and lipids benefits patients with type 2 diabetes, the long-awaited, large Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases (J-DOIT3).

First Continuous Glucose Monitor that doesn’t require routine finger pricks.